NL-OMON23245招募中不适用
A 2-step phase I study evaluating the safety of (neo-)adjuvant cisplatin-pemetrexed and stereotactic radiotherapy (SRT) for patients with stage IB non-small-cell lung cancer (NSCLC).
prof. dr. EF Smit0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Any histologically or cytologically proven NSCLC;
- •2. Stage IB NSCLC (T2N0M0);
排除标准
- •1. Pregnant or lactating women;
- •2. Concomitant treatment with any other experimental drug under investigation;
研究者
相似试验
尚未招募
不适用
A 2-step phase I study evaluating the safety of (neo-)adjuvant cisplatin-pemetrexed and stereotactic radiotherapy for patients with stage IB non-small-cell lung cancerlung carcinoma10038666lung cancerNL-OMON32798Vrije Universiteit Medisch Centrum20
招募中
不适用
Study for intraoperative imaging of prostate cancer using OTL78Prostate cancerNL-OMON21822On Target Laboratories, Inc39
已完成
1 期
Testing safety and efficacy of a live bacterial therapy for the treatment of Helicobacter pylori infectioInfection - Other infectious diseasesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonHelicobacter pylori infectionACTRN12620000923965Servatus Ltd28
进行中（未招募）
1 期
A Study Evaluating the Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab plus Lenalidomide in Patients with Relapsed or Refractory Follicular LymphomaFollicular lymphomaMedDRA version: 19.0Level: LLTClassification code 10016904Term: Follicle centre lymphoma, follicular grade I, II, III NOSSystem Organ Class: 100000004864EUCTR2015-002467-42-FRF. Hoffmann-La Roche Ltd38
进行中（未招募）
1 期
A Study Evaluating the Safety and Efficacy of Obinutuzumab in Combination with Atezolizumab plus Polatuzumab Vedotin in Patients with Relapsed or Refractory Follicular Lymphoma and Rituximab in Combination with Atezolizumab plus Polatuzumab Vedotin in Patients with Relapsed or Refractory Diffuse large B-cell LymphomaFollicular Lymphoma (FL) or Diffuse Large B-cell Lymphoma (DLBCL)MedDRA version: 20.0Level: LLTClassification code 10016904Term: Follicle centre lymphoma, follicular grade I, II, III NOSSystem Organ Class: 100000004864EUCTR2015-004845-25-DEF. Hoffmann-La Roche Ltd.36